Skin Cancer Research Review, Issue 1

In this issue:

Increased risk of skin cancer in people with a family history of melanoma
Long-term durability of dabrafenib plus trametinib for metastatic melanoma patients
5% fluorouracil is the most effective treatment for actinic keratosis
HLA mismatch confers protection against skin cancer risk in lung and heart transplant recipients
Diagnosis of non-pigmented skin cancer by convolutional neural networks
Neoadjuvant therapy with dabrafenib plus trametinib for resected melanoma
Pembrolizumab for melanoma patients with brain metastases
Immunotherapies in Merkel cell carcinoma
Basal cell carcinoma of the groin and buttocks
Discontinuation of anti-PD-1 antibody therapy in advanced melanoma

Download PDF Subscribe